Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis
Not yet recruiting
This study is being conducted to characterize the mechanism of action of crisaborole ointment
2%, by evaluation of efficacy and changes in key skin biomarkers in atopic dermatitis (AD)
lesions treated with crisaborole ointment 2% over vehicle, in subjects with mild to moderate
AD. Two identified AD skin lesions for each subject will be treated for the first 15 days,
one with crisaborole ointment 2% and one with vehicle, in a blinded manner, and biopsies for
biomarker analysis will be performed on the lesions. Following completion of the blinded
treatment period, subjects will start the 28 day open label period during which all AD
affected skin lesions will be treated with crisaborole ointment 2% twice daily.
A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatit
Not yet recruiting
This is a Phase 1 parallel-cohort study of crisaborole ointment 2% to evaluate the skin
irritation potential in adult Japanese healthy subjects in Cohort 1, and to evaluate the
safety, tolerability and PK in adult Japanese subjects with mild to moderate AD in Cohort 2.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.